Eric Meizlish joined Prendio-BioProcure as CEO in January 2024, bringing experience as a seasoned entrepreneur, operator, and investor in technology-enabled businesses. He is a co-founder of Lumere, a leading software and clinical analytics business for hospitals and health systems, and served as its President and Chief Strategy Officer until its acquisition by GHX. At GHX, which offers the healthcare industry’s largest supply chain network, he served as the Senior Vice President of Strategy and Corporate Development and was a member of the global leadership team. He also spent the first several years of his career at Citadel, where he invested in publicly traded Technology, Media, and Telecommunications companies.
Eric is a board member and advisor for several growth-stage healthcare technology businesses and serves on the investment committee of the Chicago Giving Circle, an organization focused on funding emerging not-for-profits in the Chicago area. Outside of work, he enjoys skiing, playing platform tennis, investing, and spending time with family and friends.
Eric is a graduate of Yale University with a degree in Economics and Mathematics.